RNS Number : 1876P
Assura PLC
21 May 2024
 

21 May 2024

Assura plc

Appointment of Joint Corporate Broker

Assura plc is pleased to announce that it has appointed HSBC Bank plc to act as its joint corporate broker alongside Barclays Bank plc and Stifel Nicolaus Europe Ltd, with immediate effect.

- Ends -

 

For more information, please contact:

Assura plc
David Purcell, Investor Relations Director

Tel: 0161 515 2043
Email: Investor@assura.co.uk

Finsbury Glover Hering

Gordon Simpson

HSBC Bank plc
Chloe Ponsonby / Sam McLennan 

Barclays Bank plc
Bronson Albery / Tom MacDonald

Stifel Nicolaus Europe Ltd
Mark Young / Jonathan Wilkes-Green         

Tel: 0207 251 3801
Email: Assura@Finsbury.com

Tel: +44 (0) 20 7991 8888


Tel:
+44 (0) 207 623 2323


Tel:
+44 (0) 20 7710 7600

 

Notes to Editors

Assura plc is the UK's leading specialist healthcare property investor and developer. Assura enables better health outcomes through its portfolio of more than 600 healthcare buildings, from which over six million patients are served.

A UK REIT based in Altrincham, Assura is a constituent of the FTSE 250 and the EPRA* indices. As at 31 March 2024, Assura's portfolio was valued at £2.7 billion and has a strong track record of growing financial returns and dividends for shareholders.

At Assura, we BUILD for health, having developed over 100 new healthcare buildings in our history, and at the heart of our strategy sits The Bigger Picture; Healthy Environment (E), Healthy Communities (S), Healthy Business (G).

Further information is available at www.assuraplc.com

*EPRA is a registered trademark of the European Public Real Estate Association

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
APPDZGZKGGVGDZZ